{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:06:27Z","timestamp":1792263987932,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ejca.2012.10.003","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T20:30:25Z","timestamp":1352493025000},"page":"915-922","source":"Crossref","is-referenced-by-count":102,"title":["Relapses in hepatoblastoma patients: Clinical characteristics and outcome \u2013 Experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)"],"prefix":"10.1016","volume":"49","author":[{"given":"M.","family":"Semeraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Branchereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Maibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zsiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Domerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Laithier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Roebuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Perilongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Czauderna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Brugieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2012.10.003_b0005","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2012.10.003_b0010","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","article-title":"Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study","volume":"28","author":"Zsiros","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2012.10.003_b0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00383-002-0906-0","article-title":"Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma","volume":"19","author":"Matsunaga","year":"2003","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.ejca.2012.10.003_b0020","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1200\/JCO.2006.09.7204","article-title":"Redefining the role of doxorubicin for the treatment of children with hepatoblastoma","volume":"26","author":"Malogolowkin","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2012.10.003_b0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2008-1043805","article-title":"Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94","volume":"211","author":"Fuchs","year":"1999","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.ejca.2012.10.003_b0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1399-3046.2006.00517.x","article-title":"Response of heavily treated and relapsed hepatoblastoma in the transplanted liver to single-agent therapy with irinotecan","volume":"10","author":"Ijichi","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ejca.2012.10.003_b0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2298\/ACI0902105K","article-title":"Successful treatment of second hepatoblastoma relapse \u2013 case report","volume":"56","author":"Krstovski","year":"2009","journal-title":"Acta Chir Iugosl"},{"key":"10.1016\/j.ejca.2012.10.003_b0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/mpo.10300","article-title":"Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11)","volume":"41","author":"Palmer","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2012.10.003_b0045","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00247-008-0911-0","article-title":"Percutaneous radiofrequency ablation for treatment of hepatoblastoma recurrence","volume":"38","author":"Ye","year":"2008","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.ejca.2012.10.003_b0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1399-3046.2008.01015.x","article-title":"Autologous peripheral blood stem-cell transplantation with a double-conditioning regimen for recurrent hepatoblastoma after liver transplantation \u2013 a valid therapeutic option or just too much?","volume":"13","author":"Perilongo","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ejca.2012.10.003_b0055","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ejca.2005.02.035","article-title":"The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis","volume":"41","author":"Zimmermann","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.10.003_b0060","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/1097-0142(20011215)92:12<3130::AID-CNCR10115>3.0.CO;2-#","article-title":"Small cell undifferentiated histology in hepatoblastoma may be unfavorable","volume":"92","author":"Haas","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2012.10.003_b0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","article-title":"Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology \u2013 SIOPEL 2","volume":"40","author":"Perilongo","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.10.003_b0070","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2000.18.22.3819","article-title":"Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach \u2013 results of the first prospective study of the International Society of Pediatric Oncology","volume":"18","author":"Pritchard","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2012.10.003_b0075","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.ejca.2004.01.042","article-title":"Phase II study of high-dose cyclophosphamide in relapsing and\/or resistant hepatoblastoma in children: a study from the SIOPEL group","volume":"40","author":"Cacciavillano","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.10.003_b0080","series-title":"SIOP","first-page":"745","article-title":"Irinotecan single drug treatment for children with refractory or recurrent hepatoblastoma \u2013 a phase II trial of the Childhood Liver Tumour Strategy Group (SIOPEL)","author":"Zsiros","year":"2009"},{"key":"10.1016\/j.ejca.2012.10.003_b0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1470-2045(00)00018-8","article-title":"SIOPEL trials using preoperative chemotherapy in hepatoblastoma","volume":"1","author":"Perilongo","year":"2000","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2012.10.003_b0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ejca.2012.10.003_b0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1258\/000456306777695726","article-title":"The hook effect: a need for constant vigilance","volume":"43","author":"Jassam","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ejca.2012.10.003_b0100","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1200\/JCO.1989.7.5.638","article-title":"Prognostic factors for children with recurrent Wilms\u2019 tumor: results from the Second and Third National Wilms\u2019 Tumor Study","volume":"7","author":"Grundy","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2012.10.003_b0105","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1200\/JCO.2010.32.1984","article-title":"Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy","volume":"29","author":"Chisholm","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912007915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912007915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T22:38:04Z","timestamp":1594852684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804912007915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0959804912007915"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2012.10.003","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}